Actimed Therapeutics

Develoeper of therapies for treating cancer and other chronic diseases

placeLondon, England, United Kingdom calendar_todayFounded 2017 groups4 employees language actimedtherapeutics.com

Registered entities

Innovation

11 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 422 times.

YearFilings
20131
20162
20171
20183
20193
20204
20215
20223
20233
20246
20255

Social engagement

Social engagement: 1.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

53 investors on record; lead investors include Mankind Pharma.

Investor typeCountShare
Venture capital12%
Private equity59%
Other / undisclosed4789%

Recent activity

12 Dec 2025
Event
SWCD2025 Symposium
9 Dec 2025
Event
18th Annual Conference on Sarcopenia, Cachexia, and Wasting Disorders (SCWD)
21 Nov 2025
Partnership
MANKIND PHARMA LTD
Coming soon